ArticleINSIGHTS INTO THE IMPACT OF FXR ACTIVATION ON HEPATIC AUTOPHAGY IN A NON-ALCOHOLIC STEATOHEPATITIS MODEL
ArticleINSIGHTS INTO THE IMPACT OF FXR ACTIVATION ON HEPATIC AUTOPHAGY IN A NON-ALCOHOLIC STEATOHEPATITIS MODEL
ArticleNon-alcoholic fatty liver disease: Insights into pathogenesis, molecular mechanisms, and therapy
ArticleNon-alcoholic fatty liver disease: Insights into pathogenesis, molecular mechanisms, and therapy
ArticleRole of Activin A as A Novel Marker for Diagnosis and Evaluation of Nonalchoholic Fatty Liver Disease
ArticleRole of Activin A as A Novel Marker for Diagnosis and Evaluation of Nonalchoholic Fatty Liver Disease
ArticleNon alcoholic fatty liver disease: pathogenesis, role of (TNF-α, IL-6) in hepatic inflammation and future potential nutraceutical treatment
ArticleNon alcoholic fatty liver disease: pathogenesis, role of (TNF-α, IL-6) in hepatic inflammation and future potential nutraceutical treatment
ArticleLiver Fatty Acid-binding Protein (L-FABP) as a Diagnostic Marker for Non-alcoholic Fatty Liver Disease
ArticleLiver Fatty Acid-binding Protein (L-FABP) as a Diagnostic Marker for Non-alcoholic Fatty Liver Disease